NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
出版年份 2014 全文链接
标题
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
作者
关键词
-
出版物
Chemical Science
Volume 5, Issue 8, Pages 2925-2932
出版商
Royal Society of Chemistry (RSC)
发表日期
2014-04-04
DOI
10.1039/c3sc53243g
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Biotransformations of Anticancer Ruthenium(III) Complexes: An X-Ray Absorption Spectroscopic Study
- (2013) Aviva Levina et al. CHEMISTRY-A EUROPEAN JOURNAL
- The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo
- (2013) Petra Heffeter et al. EUROPEAN JOURNAL OF CANCER
- Nanoformulation Improves Activity of the (pre)Clinical Anticancer Ruthenium Complex KP1019
- (2013) P. Heffeter et al. Journal of Biomedical Nanotechnology
- X-ray Absorption Near Edge Structure Spectroscopy to Resolve the in Vivo Chemistry of the Redox-Active Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019)
- (2013) Alfred A. Hummer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells
- (2012) Jade B. Aitken et al. Metallomics
- Anticancer Activity of Metal Complexes: Involvement of Redox Processes
- (2011) Ute Jungwirth et al. ANTIOXIDANTS & REDOX SIGNALING
- Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting
- (2011) Min Ni et al. BIOCHEMICAL JOURNAL
- Influence of ascorbic acid on the activity of the investigational anticancer drug KP1019
- (2011) Caroline Bartel et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Approaching tumour therapy beyond platinum drugs
- (2011) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- LC– and CZE–ICP-MS approaches for the in vivo analysis of the anticancer drug candidate sodium trans-[tetrachloridobis(1H-indazole)ruthenate(iii)] (KP1339) in mouse plasma
- (2011) Anna K. Bytzek et al. Metallomics
- Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin
- (2011) Michael Groessl et al. Metallomics
- Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339
- (2010) Petra Heffeter et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry
- (2010) Michael Groessl et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
- (2009) Frederike Lentz et al. ANTI-CANCER DRUGS
- KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- (2008) Christian G. Hartinger et al. CHEMISTRY & BIODIVERSITY
- Resistance against novel anticancer metal compounds: Differences and similarities
- (2008) P HEFFETER et al. DRUG RESISTANCE UPDATES
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- Electron-transfer activated metal-based anticancer drugs
- (2006) Erwin Reisner et al. INORGANICA CHIMICA ACTA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started